MedTrace Logo

Clinical and Genomic Factors for Prognosis of AIDS Primary Effusion Lymphoma

NCT02823327 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-05-11

Study results available
· View outcomes & findings →

Summary

This research trial studies clinical factors and gene expression analysis for prognosis in tissue samples from patients with acquired immune deficiency syndrome (AIDS)-related primary effusion lymphoma. Gathering health information over time and studying samples of tissue from patients in the laboratory may help doctors learn about the prognosis of patients with AIDS-related primary effusion lymphoma.

Conditions

  • AIDS-Related Primary Effusion Lymphoma

Interventions

GENETIC

Laboratory Biomarker Analysis

Correlative studies

OTHER

Medical Chart Review

Medical chart review is performed

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of California, San Diego

    collaborator OTHER

  • University of Arkansas

    collaborator OTHER

  • AIDS Malignancy Consortium

    lead NETWORK

Principal Investigators

  • Erin Reid · AIDS Malignancy Consortium

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-11
Primary Completion
2023-02-03
Completion
2023-02-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02823327 on ClinicalTrials.gov